Key points are not available for this paper at this time.
An independent reanalysis of 11 randomized clinical trials shows that oseltamivir treatment reduces the risk of lower respiratory tract complications requiring antibiotic treatment by 28% overall (95% confidence interval CI, 11%-42%) and by 37% among patients with confirmed influenza infections (95% CI, 18%-52%).
Hernán et al. (Wed,) studied this question.